Speaker: Prof. Bart van Wijmeersch, MD, PHD
Neurologist-Immunologist
Medical Head of the Univeristy MS Centre, Pelt
Universitair MS Centrum, Hasselt-Pelt ; Noorderhart hospitals, Revalidation & MS, Pelt ; Hasselt University
Pelt-Hasselt, Belgium
Prof. Bart van Wijmeersch is a neurologist specialized in Multiple Sclerosis. He is the medical director of the University MS Centre in Pelt where he leads the multidisciplinary MS-team. Furthermore, he is an associate professor of Neurology at the University of Hasselt, where he’s involved in pre-clinical as well as the clinical research on MS. He has a supporting role in all the immunological research on blood- and CSF samples of persons with MS and in EAE-animal models, as well as in the clinical rehabilitation research (BIOMED & REVAL). Immunological, Biomarker, MRI, Electrophysiological and Rehabilitation research in MS come together in this way. He has an educational role in the faculty of medicine and physiotherapy.
He’s a member of the Belgian Study Group of Multiple Sclerosis and a member of advisory boards of different pharmaceutical companies with interest in Multiple Sclerosis. He was co-founder and the first President of the ParadigMS Foundation, an organisation dedicated to education on MS to improve everyday clinical care of persons with MS. As an acknowledgment of his scientific work, he received an honorary award of the Flemish government in the summer of 2019.
Presentation title: The Current Use of OCT in MS care
Optical coherence tomography (OCT) is a technique to image and measure the different layers of the human retina. In Multiple Sclerosis (MS), an autoimmune disease of the central nervous system with neurodegenerative characteristics, the optic nerve is often involved, with demyelination and axonal damage as a consequence. Moreover, slow neurodegeneration of the brain and spinal cord takes place over time secondary to the neuroinflammation.
Therefore OCT can be a good tool to visualise and measure the retinal damage caused by MS, but also act as a surrogate marker for the more neurodegenerative process taking place inside the whole Brain. In this way OCT can help neurologists in the care for MS patients in terms of MS-prognosis, treatment choices and follow-up. During this presentation, the different aspects and possibilities of the use of OCT in current MS-care will be highlighted.